← Current compounder rows

Current NDC auxiliary source row compounder:105

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
70092-612
Product Ndc
70092-612
Product Ndc Digits
70092612
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
L.E.T. Gel 1.5 ml in 3 ml Top Syr
Proprietary Name Suffix
[empty]
Nonproprietary Name
L.E.T. Gel 1.5 ml in 3 ml Top Syr
Dosage Form Name
GEL
Route Name
TOPICAL
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
QuVa Pharma, Inc.
Establishment Name
QuVa Pharma, Inc.
Establishment Fei
[empty]
Substance Name
LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
Active Ingredients Info
60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL
History Active Ingredients Raw
LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
History Active Ingredients Info Raw
60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL
History Dosage Raw
GEL
Dea Schedule
[empty]
Package Ndc Raw
70092-612-44
Package Ndc
70092-612-44
Package Ndc Digits
7009261244
Package Ndc11
70092061244
Package Description
1.5 mL in 1 SYRINGE (70092-612-44)
Reporting Period Raw
2026-1
Reporting Period
2026-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:105
Source Row Number
105
Source Row Hash
bd0023caffd6dc237f83bb25f0e9c9b97a48ef0fd03447f63796bfcc852264f2
Import Run Id
20261122T170239Z
Loaded At
2026-11-22 17:13:49

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "70092-612",
    "DEASCHEDULE": "",
    "LABELERNAME": "QuVa Pharma, Inc.",
    "SUBSTANCENAME": "LIDOCAINE HYDROCHLORIDE ANHYDROUS; TETRACAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "GEL",
    "NDCPACKAGECODE": "70092-612-44",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "L.E.T. Gel 1.5 ml in 3 ml Top Syr",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "L.E.T. Gel 1.5 ml in 3 ml Top Syr",
    "PACKAGEDESCRIPTION": "1.5 mL in 1 SYRINGE (70092-612-44) ",
    "ACTIVEINGREDIENTSINFO": "60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:105
Source Row Number
105
Status Scope
package
Lookup Ndc
70092-612-44
Lookup Ndc Digits
7009261244
Product Ndc
70092-612
Product Ndc Digits
70092612
Package Ndc
70092-612-44
Package Ndc Digits
7009261244
Package Ndc11
70092061244
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2026-1
Reporting Period
2026-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
bd0023caffd6dc237f83bb25f0e9c9b97a48ef0fd03447f63796bfcc852264f2
Import Run Id
20261122T170239Z
Loaded At
2026-11-22 17:13:49